Theora offers an AI‑powered analytics platform that automatically ingests, normalizes, and indexes millions of clinical, scientific, regulatory, and financial records to produce market‑size estimates, de‑risking scenarios, and regulatory impact assessments. Delivered through a secure web dashboard and RESTful API, the solution enables pharmaceutical R&D, portfolio, and market‑access teams to obtain data‑backed insights in hours, reducing reliance on costly, multi‑month consulting engagements.
Funding
Funding not disclosed
Founders
Product
Problem
Biopharma organizations must integrate disparate clinical, scientific, and regulatory data sources to inform competitive intelligence, trial design, and asset valuation, but fragmented information creates blind spots and prolongs decision cycles.
Solution
Theora delivers an AI‑driven analytics platform that automatically aggregates, normalizes, and indexes millions of precedent cases—including patents, trial registries, publications, guidelines, and financial filings. By applying systematic, hallucination‑free models, the platform generates addressable‑market sizing, de‑risking scenarios, and regulatory impact assessments in hours rather than weeks. Users receive actionable reports through a secure web dashboard and can export data via RESTful APIs for downstream workflows. The solution replaces traditional multi‑month, $100k+ consulting engagements with on‑demand, subscription‑or project‑based analyses, accelerating go‑to‑market decisions while reducing cost. Built‑in validation layers ensure data fidelity and traceability across all evidence streams.
Target Audience
Primary users are pharmaceutical R&D teams, portfolio managers, and market‑access or regulatory affairs groups that require rapid, data‑backed insights for drug development and commercialization strategies.
Features
- Automated ingestion pipeline that crawls and harmonizes patents, trial data, regulatory submissions, medical guidelines, and commercial filings.
- Large‑scale precedent database (tens of millions of records) leveraged for market‑size modeling and pathway de‑risking.
- Proprietary AI models that produce “hallucination‑free” quantitative outputs with confidence intervals.
- Interactive web dashboard with customizable visualizations, scenario analysis, and exportable CSV/JSON reports.
- Secure, role‑based access and end‑to‑end encryption compliant with industry data‑privacy standards.
- RESTful API and SDKs for integration with internal R&D, market‑access, and business‑intelligence pipelines.
- Continuous update engine that refreshes source data daily to keep analyses current.